TY  - GEN
AU  - Adler,Sabine
AU  - Reichenbach,Stephan
AU  - Gloor,Andrea
AU  - Yerly,Daniel
AU  - Cullmann,Jennifer L
AU  - Villiger,Peter M
TI  - Risk of relapse after discontinuation of tocilizumab therapy in giant cell arteritis
SN  - 1462-0332
PY  - 2020///0320
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal, Humanized
KW  - administration & dosage
KW  - Biomarkers
KW  - blood
KW  - Drug Administration Schedule
KW  - Female
KW  - Follow-Up Studies
KW  - Giant Cell Arteritis
KW  - diagnostic imaging
KW  - Humans
KW  - Immunosuppressive Agents
KW  - Kaplan-Meier Estimate
KW  - Magnetic Resonance Angiography
KW  - Male
KW  - Middle Aged
KW  - Recurrence
KW  - Remission Induction
KW  - Risk Assessment
KW  - methods
KW  - Risk Factors
KW  - Withholding Treatment
N1  - Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1093/rheumatology/kez091
ER  -